In-silico trial of intracranial flow diverters confirms and expands insights from conventional clinical trials

Ali Sarrami-Foroushani, Toni Lassila, Michael Macraild, Joshua Asquith, Kit C. B. Roes, James V. Byrne, Alejandro F Frangi

Research output: Other contributionpeer-review

Original languageUndefined
DOIs
Publication statusPublished - 19 Jan 2021

Cite this